Project Title: Does Air Pollution Influence the Baseline Characteristics of Pediatric SLE? Project Summary: Childhood-onset systemic lupus erythematosus (cSLE) is a rare and severe autoimmune disease ...

This year, the Lupus Foundation of America (LFA) is pleased to announce two recipients of grants supporting pediatric lupus research. This year’s recipients are Nayimisha Balmuri, MD, Assistant ...

DENVER — Neuropsychiatric lupus is “arguably the least understood manifestation” of systemic lupus erythematosus (SLE) in children, with patients facing substantial barriers and experiencing highly ...

Systemic lupus erythematosus (SLE) is a multifactorial autoimmune rheumatic disease. Although its highest prevalence is among women of childbearing age, the disease is not confined within this ...

Please provide your email address to receive an email when new articles are posted on . Black children and those of more than one racial background were less likely to achieve LLDAS and had higher ...

Belimumab autoinjector is now approved and available for pediatric patients with lupus nephritis. The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for ...

MONDAY, June 30, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active ...

The anti-CD20 antibody, developed by Roche’s Genentech along with Biogen and already approved for multiple oncology indications, is branching into autoimmune disease. Its B cell–targeting mechanism of ...

Andrea Knight, MD, MSCE, Clinician Investigator, Division of Rheumatology, Hospital for Sick Children, and Lupus Foundation of America Medical-Scientific Advisory Council member shared, "Obtaining ...